Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,958 | 122 | 67.0% |
| Consulting Fee | $1,938 | 2 | 32.8% |
| Education | $13.78 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,772 | 41 | $0 (2022) |
| Thea Pharma Inc. | $937.50 | 1 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $610.83 | 17 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $480.42 | 11 | $0 (2021) |
| ABBVIE INC. | $429.61 | 23 | $0 (2024) |
| Alcon Vision LLC | $366.51 | 7 | $0 (2024) |
| Horizon Therapeutics plc | $250.24 | 2 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $152.57 | 4 | $0 (2020) |
| Bausch & Lomb Americas Inc. | $148.41 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $105.81 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,488 | 14 | Thea Pharma Inc. ($937.50) |
| 2023 | $379.14 | 10 | Alcon Vision LLC ($168.15) |
| 2022 | $345.09 | 17 | ABBVIE INC. ($170.01) |
| 2021 | $845.94 | 26 | Horizon Therapeutics plc ($250.24) |
| 2020 | $289.06 | 13 | Allergan, Inc. ($139.12) |
| 2019 | $1,600 | 24 | Allergan Inc. ($1,237) |
| 2018 | $525.29 | 8 | Bausch & Lomb, a division of Bausch Health US, LLC ($192.48) |
| 2017 | $437.04 | 14 | Alcon Laboratories Inc ($86.83) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: EYE CARE | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: EYE CARE | ||||||
| 10/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: EYE CARE | ||||||
| 10/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: EYE CARE | ||||||
| 09/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: EYE CARE | ||||||
| 07/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.43 | General |
| 06/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $105.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.33 | General |
| 05/30/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $142.33 | General |
| Category: Ophthalmology | ||||||
| 04/24/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.14 | General |
| 04/11/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Consulting Fee | Cash or cash equivalent | $937.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/19/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $16.33 | General |
| 11/30/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $96.00 | General |
| Category: Ophthalmology | ||||||
| 10/05/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Ophthalmology | ||||||
| 09/21/2023 | Alcon Vision LLC | Rocklatan (Drug), Simbrinza, Rhopressa | Food and Beverage | In-kind items and services | $127.02 | General |
| Category: Ophthalmology | ||||||
| 08/25/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: EYE CARE | ||||||
| 08/03/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Immunology | ||||||
| 07/13/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: EYE CARE | ||||||
| 06/16/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: EYE CARE | ||||||
| 04/10/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Ophthalmology | ||||||
| 03/27/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: EYE CARE | ||||||
| 02/23/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Ophthalmology | ||||||
| 12/12/2022 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 4,498 | 5,073 | $1.2M | $261,865 |
| 2022 | 14 | 4,396 | 4,915 | $1.2M | $254,135 |
| 2021 | 14 | 4,833 | 5,463 | $1.3M | $298,112 |
| 2020 | 11 | 4,327 | 4,910 | $916,974 | $250,302 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 904 | 1,382 | $356,052 | $77,442 | 21.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 860 | 868 | $310,928 | $63,639 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 382 | 426 | $155,549 | $33,551 | 21.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 789 | 806 | $141,715 | $32,177 | 22.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 837 | 842 | $87,467 | $19,026 | 21.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 98 | 98 | $41,751 | $9,612 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $28,559 | $5,940 | 20.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 26 | 26 | $24,445 | $5,630 | 23.0% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 19 | 27 | $18,756 | $4,724 | 25.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 234 | 239 | $18,854 | $4,351 | 23.1% |
| 92134 | Imaging of retina | Office | 2023 | 137 | 147 | $16,835 | $4,093 | 24.3% |
| 92250 | Photography of the retina | Office | 2023 | 35 | 35 | $3,707 | $842.83 | 22.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 117 | 117 | $3,786 | $836.89 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 861 | 1,271 | $330,854 | $71,054 | 21.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 770 | 782 | $282,318 | $59,987 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 451 | 506 | $186,365 | $38,508 | 20.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 724 | 739 | $130,870 | $28,874 | 22.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 830 | 835 | $87,550 | $19,737 | 22.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 96 | 96 | $41,164 | $8,425 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $36,027 | $7,692 | 21.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 21 | 21 | $19,805 | $4,931 | 24.9% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 225 | 225 | $18,083 | $4,268 | 23.6% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2022 | 17 | 24 | $16,761 | $4,041 | 24.1% |
| 92134 | Imaging of retina | Office | 2022 | 125 | 139 | $16,075 | $3,814 | 23.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 147 | 147 | $4,829 | $1,108 | 22.9% |
About Dr. Douglas Stokes, M.D
Dr. Douglas Stokes, M.D is a Ophthalmology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639127046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Stokes, M.D has received a total of $5,909 in payments from pharmaceutical and medical device companies, with $1,488 received in 2024. These payments were reported across 126 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,958).
As a Medicare-enrolled provider, Stokes has provided services to 18,054 Medicare beneficiaries, totaling 20,361 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Greenville, SC
- Active Since 05/05/2006
- Last Updated 04/19/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1639127046
Products in Payments
- IYUZEH (Drug) $937.50
- LUMIGAN (Drug) $495.17
- VYZULTA (Drug) $436.36
- rocklatan (Drug) $317.49
- Rhopressa (Drug) $274.31
- TEPEZZA (Drug) $250.24
- VUITY (Drug) $201.56
- Rocklatan (Drug) $198.94
- ENTYVIO (Biological) $105.81
- ORA (Device) $101.90
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $100.57
- LOTEMAX SM (Drug) $99.97
- Syfovre (Drug) $96.00
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $74.64
- RESTASIS MULTIDOSE (Drug) $68.97
- COMBIGAN (Drug) $62.54
- DURYSTA (Drug) $61.55
- Tecnis 1-piece IOL (Device) $59.78
- ACTHAR (Biological) $59.50
- XIIDRA (Drug) $57.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Greenville
Alan Leahey, Md, MD
Ophthalmology — Payments: $35,694
Dr. William Ballinger, M.d, M.D
Ophthalmology — Payments: $10,552
Brian Welcome, M.d, M.D
Ophthalmology — Payments: $5,885
Brian Shelley, M.d, M.D
Ophthalmology — Payments: $5,443
Dr. Ann Ostrovsky, M.d, M.D
Ophthalmology — Payments: $4,797
Dr. Melissa Ixcamey, M.d, M.D
Ophthalmology — Payments: $4,418